US4931445A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Agents for treatment of male impotence
Assignee: Boston University
•
Filing: 1988-10-06
•
Granted: 1990-06-05
•
Expires: 2008-10-06
Abstract
Abstract Etoperidone and its pharmaceutically acceptable salts are useful in the treatment of male sexual impotence.
Inventors
- 👤 Irwin Goldstein
- 👤 Inigo S. de Tejada
- 👤 Leslie A. Riblet
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 22:53
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/495; A61P; A61P13/00; A61P13/02; A61P15/00
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
33 words
A method for treating male sexual impotence which comprises administering a non-toxic therapeutically effective dose of etoperidone or a pharmaceutically acceptable acid addition salt thereof to a patient in need of such treatment.
Claim 2
Independent Claim
33 words
A method for treating male sexual impotence which comprises administering a non-toxic therapeutically effective dose of etoperidone or a pharmaceutically acceptable acid addition salt thereof to a patient in need of such treatment.
Claim 3
Dependent Claim
17 words
The method of claim 1 wherein etoperidone hydrochloride is employed and dosage is by the oral route.
Claim 4
Dependent Claim
25 words
The method of claim 2 wherein said patient is an adult and a daily dose of from about 50 mg to 400 mg is employed.
Claim 5
Dependent Claim
14 words
The method of claim 3 wherein said daily dose is divided and administered b.i.d.
Claim 6
Dependent Claim
14 words
The method of claim 3 wherein said daily dose is divided and administered t.i.d.
Claim 7
Dependent Claim
17 words
The method of claim 1 wherein etoperidone hydrochloride is employed and is administered directly to the penis.
Claim 8
Dependent Claim
15 words
The method of claim 6 wherein the administration is by injection into penile erectile tissue.
Claim 9
Dependent Claim
18 words
The method of claim 6 wherein the dose is from about 2 to 8 mg of etoperidone hydrochloride.
References Cited (Backward Citations)
US3857845A
Cited
US4132791A
Cited
US4162318A
Cited
US4127118A
Cited
US4127118B1
Cited
US4687771A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1993-06-04 | 1993-12-04 | 1994-06-05 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1997-06-04 | 1997-12-04 | 1998-06-05 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2001-06-04 | 2001-12-04 | 2002-06-05 | $7700.00 | Window Closed / Lapsed |